Search KLH Site
Find Articles by Tags
Addiction (18) Adjuvant - Alum (1) Adjuvant - GPI-0100 (1) Adjuvant - IL-4 (9) Adjuvant GM-CSF (16) Adjuvant KLH (4) Adjuvant Oil / Surfactant (4) Adjuvant QS-21 (25) Age & Physical Activity (3) Allergen-specific immunotherapy (1) Allergy – Pollen (2) Alzheimer's Disease (3) Antibody Response (35) Antibody Response IgA (14) Antibody Response IgE (6) Antibody Response IgG (106) Antibody Response IgM (71) Antibody Response IgY (1) APEC (1) Assay - Bioassay (2) Assay - Carbohydrate Microarray (1) Assay - ELISA (55) Assay - ELISPOT (7) Assay - Immunoassay (8) Assay - InVitro (18) Assay - InVivo (1) Atopic Dermatitis (1) Autoimmune Disease (1) B-epitope (1) Bone Marrow Transplant (6) Cancer (6) Cancer - Bladder (16) Cancer - Brain & CNS (8) Cancer - Breast (15) Cancer - Cervical (1) Cancer - Colorectal (10) Cancer - Esophageal (1) Cancer - Female Reproductive (7) Cancer - Leukemia (2) Cancer - Lung (4) Cancer - Lymphoma (25) Cancer - Melanoma (37) Cancer - Mesothelioma (1) Cancer - Myeloma (15) Cancer - Other (2) Cancer - Ovarian (3) Cancer - Pancreas (1) Cancer - Pediatric (3) Cancer - Peritoneal (2) Cancer - Prostate (9) Cancer - Renal (13) Cancer - Sarcoma (2) Clostridium difficile (5) Crohn's Disease (2) Cross-Reactive Antigens (6) Delayed-type hypersensitivity response (1) Dendritic Cell (66) Developmental (10) Diabetes (2) Disease Resistence (1) DNP-Ficoll (2) DTH (67) Environmental (15) Escherichia coli (1) Fingolimod (Gilenya) (1) Healthy Volunteers (18) HealthyAntibody Response - IgA (1) Hepatitis (2) HIV (11) HPV (3) Husbandry (3) Hypertension (1) id-KLH (29) IL 1 (4) IL 12 (2) IL 15 (1) IL 2 (10) IL 5 (1) IL 6 (1) IL 7 (1) Immune Disease - Autoimmune (13) Immune Disease - Primary (2) Immune Disease – Secondary (1) Immune Response - Cellular (187) Immune Response - Humoral (259) Immune Response Humoral (2) Immunotoxicity (37) Infection (1) Infectious Disease (5) Inflammatory Disease (1) Intradermal KLH (1) Kidney (1) KLH-BEC2 (1) KLH-BP16 (1) KLH-BPO (1) KLH-Conjugate (69) KLH-EGFR (2) KLH-FITC (1) KLH-Ganglioside (16) KLH-Globo H (7) KLH-GM2 (1) KLH-hD1 (1) KLH-HGP-30 (1) KLH-IL (1) KLH-Kinoid (8) KLH-Lewis Y (3) KLH-MUC (8) KLH-Oxycodone (2) KLH-sTn (9) KLH-TF (5) KLH-TN (3) Model - Canine (6) Model - Guinea Pig (10) Model - Livestock (10) Model - Mouse (73) Model - Other (32) Model - Primate (12) Model - Rat (51) Multiple Sclerosis (1) Nasal (3) Natrural Antibody (1) Neonatal (2) NK Cells (1) NSAID (1) Oral KLH (9) Oxycodone (3) Parasitic Disease (6) Pediatric (1) Plant-made (2) PLNA (1) Population Density (3) Psoriasis (1) Review Article (2) Rheumatoid Arthritis (11) Rituximab (Rituxan) (4) Russian thistle (1) Sal k 1 (1) Stress (8) Systemic Lupus Erythematosus (SLE) (7) TACA (2) TDAR (127) Therapeutics - KLH Alone (15) Transplant (6) Ultra Violet radiation (1) Uveitis (1) VEGF (3) Veterinary (1)
Terms and Privacy

KLH in Publications

Publications of scientific research involving KLH. Abstracts or full text articles are available by link to outside sites. If you know of a KLH-related publication that is not yet on KLH Site™, let us know.

(in order by date)

Entries in KLH-Kinoid (8)

Friday
Jan012016

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.

Semerano LDuvallet EBelmellat NMarival NSchall NMonteil MGrouard-Vogel GBernier ELecouvey MHlawaty HMuller SBoissier MCAssier E.

Angiogenesis. 2016 Jan;19(1):39-52. doi: 10.1007/s10456-015-9487-0. Epub 2015 Sep 29.

Wednesday
Sep022015

IFNα kinoid induces neutralizing anti-IFNα antibodies that decrease the expression of IFN-induced and B cell activation associated transcripts : analysis of extended follow-up data from the IFN-K phase I/II study

J. Ducreux1, P. Vandepapeliere2, F. Colaone2, C. Roucairol2, T. Croughs2, F. A. Houssiau1, G. Grouard-Vogel2, B. Lauwerys1
(1Université catholique de Louvain, Brussels, Belgium, 2Neovacs, Paris, France)

Poster presented September 4, 2015

Lupus 2015
11th International Congress on Systemic Lupus Erythematosus
Vienna, Austria
Sept. 2 - 6, 2015

Friday
Feb012013

Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.

Lauwerys BR, Hachulla E, Spertini F, Lazaro E, Jorgensen C, Mariette X, Haelterman E, Grouard-Vogel G, Fanget B, Dhellin O, Vandepapelière P, Houssiau FA

Arthritis Rheum. 2013 Feb;65(2):447-56. doi: 10.1002/art.37785

Friday
Jun082012

Active Therapeutic Immunization with TNF-Kinoid in Rheumatoid Arthritis Patients with Secondary Resistance to TNFα Antagonists is safe and immunogenic.

Durez P, Miranda P , Toncheva A, Berman A, Rillo OL, Boutsen Y, Kehler T, Mociran E, Soto Saez LA, Fautrel B, Mariette X, Solakov P, Lucero E, Vlak T, Grazio S, Mastrovic K, Chiriac R, Grouard-Vogel G, Dhellin O, Ouary S, Vandepapelière P, Boissier MC

Eular 2012 (June 8-9)

Tuesday
May012012

Modulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoid.

Assier E, Semerano L, Duvallet E, Delavallée L, Bernier E, Laborie M, Grouard-Vogel G, Larcier P, Bessis N, Boissier MC

Clin Vaccine Immunol. 2012 May;19(5):699-703. doi: 10.1128/CVI.05649-11. Epub 2012 Mar 21.

Wednesday
Jun012011

Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus.

Monday
Mar012010

VEGF targeting by active immunisation improves joint inflammation and destruction in a murine model of rheumatoid arthritis

E AssierL SemeranoL DelavalleeD DamotteG Grouard-VogelE BernierD ZaguryN Bessis, M C Boissier

Ann Rheum Dis2010;69:A46 doi:10.1136/ard.2010.129635h

Saturday
Apr142007

VEGF kinoid vaccine, a therapeutic arm against tumor angiogenesis and metastases

Helene Le BuanecFarhad Haghighi RadElena RitsouGeorges Uzan and Daniel Zagury